The combination of anti-Aβ/anti-NLRP3 antibodies prevented inflammasome activation, which resulted in a decrease in IL-1β and tau phosphorylation in 3xTg-AD mice [49]. This evidence concerns the gene IL1B and Alzheimer disease.